Senior Manager
Nexcelom from PerkinElmer, United Kingdom
Scott Cribbes PhD : Market Development leader for Nexcxelom products in EMEAI
Biochemistry Honours Degree from Glasgow University followed by a PhD in Cancer biology from Beatson Institute for Cancer Research. Five years of research and assay development techniques at British Biotech, Axis Shield and AstraZeneca. Since 2001, I have worked at Applied Biosystems and Life Technologies in the area of imaging, HTS screening, and reagents solutions. Since 2009, I have worked with the Celigo image cytometer technology from development to released product for brightfield capability at Cyntellect to its current 5-channel format at Nexcelom, which continues development within the Perkin Elmer family. The Celigo image cytometer and Nexcelom’s family of cell counters seamlessly fits into the imaging portfolio of Perkin Elmer allowing us to provide scientist with innovative solutions for their research. I have now transitioned into the Market Development leader for Nexcelom products in EMEAI after running the EMEAI business as its development director for tteh last four years.
Thursday, May 25, 2023
11:30 – 12:00 CET